KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Exact Sciences (EXAS) over the last 14 years, with Q4 2025 value amounting to $8.4 million.

  • Exact Sciences' Change in Accured Expenses rose 70763.14% to $8.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.2 million, marking a year-over-year decrease of 15366.03%. This contributed to the annual value of -$5.2 million for FY2025, which is 15366.03% down from last year.
  • According to the latest figures from Q4 2025, Exact Sciences' Change in Accured Expenses is $8.4 million, which was up 70763.14% from -$626000.0 recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Change in Accured Expenses ranged from a high of $12.8 million in Q2 2024 and a low of -$7.2 million during Q2 2025
  • Its 4-year average for Change in Accured Expenses is $594750.0, with a median of -$893500.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in Exact Sciences' Change in Accured Expenses was 475086.21% (2023), while the steepest drop was 33888.45% (2023).
  • Exact Sciences' Change in Accured Expenses (Quarter) stood at $1.3 million in 2022, then soared by 502.77% to $7.6 million in 2023, then plummeted by 118.26% to -$1.4 million in 2024, then surged by 707.63% to $8.4 million in 2025.
  • Its Change in Accured Expenses was $8.4 million in Q4 2025, compared to -$626000.0 in Q3 2025 and -$7.2 million in Q2 2025.